Clinical Trial Update: Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing Casdatifan plus cabozantinib versus placebo plus cabozantinib in patients with advanced or metastatic clear cell renal cell c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Drugs mentioned

• Casdatifan
• cabozantinib (cabozantinib)

Snippet

Sponsor: Arcus Biosciences, Inc. | Conditions: Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma | Phase 3 | Status: RECRUITING